No Data
HC Wainwright Adjusts Price Target on United Therapeutics to $400 From $300, Maintains Buy Rating
United Therapeutics Is Maintained at Buy by HC Wainwright & Co.
H.C. Wainwright Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $400
United Therapeutics Analyst Ratings
Express News | United Therapeutics Corporation : H.c. Wainwright Raises Target Price to $400 From $300
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
151652693 : There are many theories that do not touch the QE factor that caused the rise and harvest of global finance
151336027 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
151830249 :![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d.png)
151078437 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
151817588 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
View more comments...